Phase 1/2 trial of radiotherapy in combination with TTI-101 in patients with borderline resectable pancreatic cancer
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
![Photograph of Sana Karam](https://som.ucdenver.edu/FIMS/Content/faculty/21666/CU-Doctors-21666.jpg)
Sana Karam
Study ID
Protocol Number: 22-0734
More information available at ClinicalTrials.gov: NCT06141031
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers